News Daily News Study Highlights Disparity Between Pre-, Postmarket Study Outcomes for DES Caitlin E. Cox June 13, 2014
News Conference News EuroPCR 2014 CENTURY II: Bioresorbable Polymer DES Stands up to Everolimus-Eluting Device Caitlin E. Cox May 20, 2014
News Daily News Registry: DAPT Discontinuation Less Associated With Second-Gen DES Thrombosis Compared to First-Gen DES L.A. McKeown April 11, 2014
News Daily News Analysis Shows DES Reduce TVR but Not Mortality vs. BMS in Extreme Elderly December 30, 2013
News Conference News ACC 2013 Is Nobori NEXT? Biodegradable-Polymer DES Noninferior to EES Jason Kahn March 09, 2013
News Daily News EES Outperform First-Generation DES in Treatment of CTOs L.A. McKeown December 27, 2012
News Daily News Real-World Equivalence Seen for Zotarolimus- and Everolimus-Eluting Stents Caitlin E. Cox December 26, 2012
News Daily News Korean Registry Confirms Edge of Everolimus- Over Zotarolimus-Eluting Stents September 19, 2012
News Conference News ESC 2012 OCTOPUS Looks at Vessel Healing After DES vs. BMS Plus Paclitaxel Balloon Caitlin E. Cox August 29, 2012
News Conference News ESC 2012 Stent Thrombosis Surprise: Rates Low, Similar for Endeavor and Cypher at 3 Years August 27, 2012
News Conference News EuroPCR 2012 EuroPCR 2012: Biodegradable Devices, Imaging Take Center Stage Caitlin E. Cox May 22, 2012
News Daily News EVOLVE Published: Bioabsorbable EES Matches Permanent-Polymer Version February 21, 2012
News Daily News Resolute Integrity: New Zotarolimus-Eluting Stent Gains FDA Approval L.A. McKeown February 20, 2012
News Industry News Elixir Medical Corporation Announces Successful Completion of First-In-Man Study Enrollment for Fully Bioresorbable Drug Eluting Coronary Scaffold System November 02, 2011
News Daily News ISAR-CABG Published: DES Preferred for Saphenous Vein Graft Lesions Jason Kahn September 12, 2011
News Daily News Drug-Eluting Balloons Show ‘Impressive’ Results in Below-the-Knee Lesions Jason Kahn September 08, 2011